Late previous week, the American Association for Laboratory Accreditation (A2LA) granted ISO/IEC 17065 accreditation to Individuals for Risk-free Access (ASA). This is the initially accreditation at any time issued to a solution certification human body in the cannabis current market.
ASA is a member-based mostly corporation founded in 2002 that seeks to assure safe and sound and lawful access to cannabis for healthcare uses and study. Back in 2016, A2LA and ASA partnered on a collaboration to develop the Patient Centered Certification (PFC) system.
What commenced as a supplement to ISO 17025 for cannabis tests labs to demonstrate a commitment to individual security, has developed into a far more in depth certification and consulting method that gives education, business companies, firm certifications. With the ISO 17065 accreditation, ASA can now produce PFC certifications that confidently recognize trustworthy and superior-top quality medical hashish products, business and providers.
Jonathan Fuhrman, program supervisor at A2LA, claims this is a significant milestone for ASA’s platform. “ISO/IEC 17065 and solution certification can play a decisive part in the evolution of cannabis as drugs,” suggests Fuhrman. “With its high benchmarks for competence and impartiality, adopting ISO/IEC 17065 represents a major win for healthcare suppliers and individuals.”
Heather Despres, the director of ASA’s Affected individual Concentrated Certification program, suggests she is thrilled to be the very first cannabis compliance corporation to attain the accreditation. “The PFC software was formulated by ASA in an effort to proceed our dedication to guard clients, numerous of whom are medically fragile, and buyers who could be searching for drugs exterior of regular medicinal channels,” states Despres. “There is no other procedure that can exhibit that ongoing commitment extra than attaining ISO 17065 accreditation.”